- Home
- STEP vs ALKS Comparison
STEP vs ALKS Comparison
Compare STEP & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEP
- ALKS
- Stock Information
- Founded
- STEP 2007
- ALKS 1987
- Country
- STEP United States
- ALKS Ireland
- Employees
- STEP N/A
- ALKS N/A
- Industry
- STEP Finance/Investors Services
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- STEP Finance
- ALKS Health Care
- Exchange
- STEP Nasdaq
- ALKS Nasdaq
- Market Cap
- STEP 4.8B
- ALKS 5.1B
- IPO Year
- STEP 2020
- ALKS 1991
- Fundamental
- Price
- STEP $61.34
- ALKS $29.06
- Analyst Decision
- STEP Buy
- ALKS Strong Buy
- Analyst Count
- STEP 7
- ALKS 13
- Target Price
- STEP $64.00
- ALKS $40.38
- AVG Volume (30 Days)
- STEP 580.5K
- ALKS 2.0M
- Earning Date
- STEP 08-07-2025
- ALKS 07-29-2025
- Dividend Yield
- STEP 2.44%
- ALKS N/A
- EPS Growth
- STEP N/A
- ALKS 21.99
- EPS
- STEP N/A
- ALKS 2.08
- Revenue
- STEP $1,352,716,000.00
- ALKS $1,505,296,000.00
- Revenue This Year
- STEP N/A
- ALKS N/A
- Revenue Next Year
- STEP $23.32
- ALKS $3.33
- P/E Ratio
- STEP N/A
- ALKS $13.62
- Revenue Growth
- STEP 87.87
- ALKS N/A
- 52 Week Low
- STEP $40.07
- ALKS $25.56
- 52 Week High
- STEP $70.38
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- STEP 58.40
- ALKS 57.64
- Support Level
- STEP $54.06
- ALKS $26.07
- Resistance Level
- STEP $62.63
- ALKS $28.73
- Average True Range (ATR)
- STEP 2.15
- ALKS 0.84
- MACD
- STEP 0.21
- ALKS 0.32
- Stochastic Oscillator
- STEP 87.51
- ALKS 97.67
About STEP StepStone Group Inc.
StepStone Group Inc operates as a fully integrated private markets solution provider. The company provides customized investment solutions and advisory and data services. It provides investment solutions in the areas of private equity, real estate, private debt, and infrastructure and real assets. The company consists of a single operating segment and a single reportable segment for accounting and financial reporting purposes.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.